{
  "symbol": "MDT",
  "name": "Medtronic",
  "sector": "Health Care",
  "industry": "Health Care Equipment",
  "date_added": "1986-10-31",
  "headquarters": "Dublin, Ireland",
  "founded": "1949",
  "market_cap": 113122.451456,
  "pe_ratio": 24.457066,
  "forward_pe": 15.092308,
  "eps": 3.61,
  "revenue": 33536.999424,
  "profit_margin": 0.13901,
  "debt_to_equity": 61.393,
  "return_on_equity": 0.09508,
  "dividend_yield": 3.26,
  "current_price": 88.30000305175781,
  "year_high": 95.49281108529841,
  "year_low": 74.13124191289698,
  "price_change_1d": -0.3160970574723019,
  "price_change_1w": -0.5070388149207746,
  "price_change_1m": 1.494256381330819,
  "description": "Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscie",
  "website": "https://www.medtronic.com",
  "employees": 95000,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 96.57852,
  "recommendation": 2.09091,
  "number_of_analysts": 27,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 112.45,
    "target_low": 78.0,
    "target_mean": 96.57852,
    "target_median": 95.0
  },
  "last_updated": "2025-07-09T11:25:29.996234",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}